Adherium Limited (ASX:ADR)

Market Cap	2.85M -67.1%
Revenue (ttm)	2.10M +157.0%
Net Income	-14.16M
EPS	-0.30
Shares Out	54.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	79,153
Open	0.0530
Previous Close	0.0520
Day's Range	0.0520 - 0.0530
52-Week Range	0.0520 - 0.8000
Beta	1.14
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Adherium

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use and improve health outcomes in chronic diseases. The company offers Hailie Smartinhaler, a cloud-based platform which captures medication use data from Bluetooth enabled sensors which wrap around patient inhalers and provide real-time feedback to patients; Hailie Smartinhaler Sensors, a device coverage that works for Rescuer/Reliever and Preventer inhalers; Hailie solution; and Hailie Remote Patien...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADR

Financial Performance

In fiscal year 2026, Adherium's revenue was 2.10 million, an increase of 157.02% compared to the previous year's 817,237. Losses were -14.16 million, 11.7% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error